Revisiting the central aortopulmonary shunt procedure

Area of Science:

• Pediatric Cardiology
• Congenital Heart Surgery
• Vascular Surgery

Background:

• Cyanotic congenital heart defects (CCHDs) often involve hypoplastic pulmonary arteries, requiring surgical palliation.
• The central aortopulmonary shunt is a surgical technique used to improve pulmonary blood flow in these complex conditions.

Purpose of the Study:

• To evaluate the safety and efficacy of the central aortopulmonary shunt technique using a polytetrafluoroethylene (PTFE) graft.
• To assess the impact of this procedure on pulmonary artery growth and systemic oxygenation in infants with CCHDs.

Main Methods:

• Retrospective analysis of 10 pediatric patients (mean age 4.3 months) who underwent central aortopulmonary shunt with a PTFE graft between January 2019 and June 2022.
• Data collected included demographic, preoperative, operative, and postoperative parameters, along with Nakata indices before and after the procedure.

Main Results:

• The procedure was used as a first-step palliation in 40% of patients and for those with well-developed ventricles in 60%.
• Median follow-up was 12 months, with a mean systemic arterial saturation of 89.3%.
• No mortality was observed in the study cohort.

Conclusions:

• The central aortopulmonary shunt procedure is a reliable technique for establishing antegrade blood flow.
• It facilitates growth of hypoplastic pulmonary arteries with minimal risk of shunt thrombosis or overflow.
• This surgical approach offers a safe and effective option for palliating complex cyanotic congenital heart defects.